Urgent.News

What's breaking now, across thousands of outlets.

Business

Korea Times to deliver KIS-powered investor insights

The Korea Times signed an agreement with Korea Investors Service (KIS), a credit ratings agency, on Friday to collaborate on research content. Under the agreement, the two sides will cooperate on the distribution of research reports, market commentaries and data-driven analytical materials. KIS is one of Korea's leading credit ratings agencies and an affiliate of Moody's. The signing ceremony was…

Korea Times to deliver KIS-powered investor insights

The Korea Times has entered into an agreement with Korea Investors Service (KIS), a prominent credit ratings agency, to work together on research content. This collaboration will see the sharing of research reports, market commentaries, and data-driven analytical materials between the two companies. KIS, which is affiliated with Moody's, is one of Korea's leading credit rating agencies. The signing ceremony took place in Seoul and was attended by Korea Times President-Publisher Oh Young-jin and KIS CEO Patrick Yoon.

Oh Young-jin expressed that it is particularly significant for the two organizations to establish cooperation based on clear and transparent guidelines, while respecting each other's intellectual property and expertise. He further stated that combining KIS's expertise with the global reach of the Korea Times will generate strong synergies.

Yoon, in turn, highlighted the potential for broader collaboration. He mentioned that by sharing more of their research and expertise, particularly in credit ratings, the partnership aims to contribute to a better understanding and analysis of market conditions.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at koreatimes.co.kr →

More in Business

Samsung Biologics Bets on Peptides with Trillion-Won Rights Offering

Samsung Biologics is undertaking a massive paid-in capital increase worth 3 trillion won (about $2.17 billion) to fully initiate the acquisition of ‘PolyPeptide Group,’ a Swiss company specializing in…

  • Samsung Biologics raises 3 trillion won to acquire PolyPeptide Group
  • Deal aims to dominate rapidly growing peptide market
  • Post-acquisition, Samsung to have 1.385 million liters production capacity by 2032

Næringslivets konge

Kong Harald V gikk bort fredag morgen, 89 år gammel. Gjennom sin kongsgjerning viste han stort…

More from Friday 28 August →